Other Research Projectsorange

RAS®, which stands for redirecting antibody specificity, is a proprietary Tripep platform technology. Activities on the RAS® project, relating to HIV, continue. RAS® molecules act as adapters redirecting existing antibodies in the bloodstream so that they neutralize HIV. HIV-binding peptides coupled to a sugar structure, Gal-alfa1,3-Gal, which all humans have antibodies against, have been prepared and are now being tested for inhibiting HIV and for the antibody-assisted neutralization of HIV-infected cells in vitro.